Scientific Interest
CJC-1295 with DAC (Drug Affinity Complex) is a synthetic growth hormone–releasing hormone (GHRH) analog studied in peptide and endocrine research. Researchers investigate its interaction with the GHRH receptor and downstream signaling pathways associated with growth hormone regulation. The DAC modification is of particular scientific interest because it alters the peptide's interaction and persistence within biological systems, making it useful for studying prolonged GHRH-mediated signaling.
Research Focus & Scientific Landscape
Active areas of scientific investigation may include:
GHRH receptor signaling
Growth hormone secretion pathways
Pituitary endocrine signaling
Growth hormone axis research
IGF-1 and downstream endocrine signaling
Peptide–receptor interactions
Pharmacokinetic and peptide-stability research
Prolonged receptor-signaling mechanisms
Structure–activity relationship studies
CJC-1295 with DAC is of scientific interest in peptide and endocrine research, particularly for investigating how modified GHRH analogs influence receptor signaling and growth hormone–related pathways under controlled research conditions.
Research Purpose: For scientific and investigational research only. Not intended for treatment, diagnosis, prevention, or therapeutic use.